Pastina, P., Nardone, V., Botta, C., Croci, S., Tini, P., Battaglia, G., . . . Correale, P. (2017). Radiotherapy prolongs the survival of advanced non-small-cell lung cancer patients undergone to an immune-modulating treatment with dose-fractioned cisplatin and metronomic etoposide and bevacizumab (mPEBev). Oncotarget.
Stile di citazione ChicagoPastina, Pierpaolo, et al. "Radiotherapy Prolongs the Survival of Advanced Non-small-cell Lung Cancer Patients Undergone to an Immune-modulating Treatment With Dose-fractioned Cisplatin and Metronomic Etoposide and Bevacizumab (mPEBev)." Oncotarget 2017.
Citazione MLAPastina, Pierpaolo, et al. "Radiotherapy Prolongs the Survival of Advanced Non-small-cell Lung Cancer Patients Undergone to an Immune-modulating Treatment With Dose-fractioned Cisplatin and Metronomic Etoposide and Bevacizumab (mPEBev)." Oncotarget 2017.